For citations:
Deshkina T.I., Bolotina L.V., Golubev P. ., Gabuniya I.E., Ruban M.S., Fedenko A.A., Kaprin A.D. De-escalation of neoadjuvant therapy as an option for patients with HER2 positive breast cancer. Malignant tumours. 2023;13(3):29-36. (In Russ.) https://doi.org/10.18027/2224-5057-2023-13-3-29-36
Email this article 